explore -WSS

explore

author：leisure time 2025-09-02 08:15:32 - browse：3

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： AI for drug discovery: Experts on separating hype from reality

entertainment

WSS

At Orexo, a ‘turning point’ for everything but digital health

A public scorecard can help hold safety

Key House panel plots a new health care package

Most antidepressants don't work on kids, teens, study finds

Custom gene therapy hints at new path for rare disease treatments

Empower primary care with adequate payments and technology

focus

explore

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sanofi seeks simpler, safer CRISPR sickle cell cure

Activists slam private health insurers over coverage restrictions

How dance can help nurses traumatized by Covid

In age of alternative facts, a scholarly course on calling out crap

Why hospitals are withdrawing from US News rankings

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Primary care doctor shortage won't be solved by free med school tuition

How one medical school became remarkably diverse

Class action alleges UnitedHealth concealed DOJ probe

leisure time

Why hospitals are withdrawing from US News rankings

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

The creative science of coining drug names

Class action alleges UnitedHealth concealed DOJ probe

Brain technologies pose threats that are all too real, experts warn

AI for drug discovery: Experts on separating hype from reality

entertainment

leisure time

focus

hotspot